APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncolytic Virus Therapy

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Selected research

Market Structure

Global Oncolytic Virus Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

25 December 2025197 pages

Choose your research edition.

Industry ResearchOncolytic Virus Therapy Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncolytic Virus Therapy Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Oncolytic Virus Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncolytic Virus Therapy Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncolytic Virus Therapy Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.

North America and Europe are the main markets, each accounting for about 40% of the market.

Read the full market overview

Report Includes

This report provides an overview of the global Oncolytic Virus Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oncolytic Virus Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oncolytic Virus Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Oncolytic Virus Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Oncolytic Virus Therapy Segment by Company

Amgen

Oncolytics Biotech

Viralytics

Transgene SA

Oncolys BioPharma

Targovax

PsiOxus Therapeutics

SillaJen Biotherapeutics

Sorrento Therapeutics

Lokon Pharma

Genelux Corporation

Vyriad

TILT Biotherapeutics

Cold Genesys

Oncolytic Virus Therapy Segment by Type

HSV-based Oncolytic Viruses

Adenoviruses-based Oncolytic Viruses

Vaccinia Virus-based Oncolytic Viruses

Vesicular Stomatitis Virus-based Oncolytic Viruses

Newcastle Disease Virus-based Oncolytic Viruses

Oncolytic Virus Therapy Segment by Application

Melanoma

Prostate Cancer

Breast Cancer

Ovarian Cancer

Others

Oncolytic Virus Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncolytic Virus Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncolytic Virus Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncolytic Virus Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Oncolytic Virus Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oncolytic Virus Therapy industry.

Chapter 3: Detailed analysis of Oncolytic Virus Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncolytic Virus Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of HSV-based Oncolytic Viruses Table 3. Key Players of Adenoviruses-based Oncolytic Viruses Table 4. Key Players of Vaccinia Virus-based Oncolytic Viruses Table 3. Key Players of Vesicular Stomatitis Virus-based Oncolytic Viruses Table 4. Key Players of Newcastle Disease Virus-based Oncolytic Viruses Table 5. Global Oncolytic Virus Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Melanoma Table 7. Key Players of Prostate Cancer Table 8. Key Players of Breast Cancer Table 9. Key Players of Ovarian Cancer Table 10. Key Players of Others Table 11. Global Oncolytic Virus Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Oncolytic Virus Therapy Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Oncolytic Virus Therapy Market Share by Region (2021-2026) Table 14. Global Oncolytic Virus Therapy Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Oncolytic Virus Therapy Market Share by Region (2027-2032) Table 16. Oncolytic Virus Therapy Industry Trends Table 17. Oncolytic Virus Therapy Industry Drivers Table 18. Oncolytic Virus Therapy Industry Opportunities and Challenges Table 19. Oncolytic Virus Therapy Industry Restraints Table 20. Global Oncolytic Virus Therapy Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Oncolytic Virus Therapy Revenue Market Share by Company (2021-2026) Table 22. Global Oncolytic Virus Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Oncolytic Virus Therapy Key Company Head Office and Area Served Table 24. Global Oncolytic Virus Therapy Company, Product Type & Application Table 25. Global Oncolytic Virus Therapy Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Oncolytic Virus Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Oncolytic Virus Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Oncolytic Virus Therapy Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Oncolytic Virus Therapy Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Oncolytic Virus Therapy Revenue Market Share by Type (2021-2026) Table 32. Global Oncolytic Virus Therapy Revenue Market Share by Type (2027-2032) Table 33. Global Oncolytic Virus Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Oncolytic Virus Therapy Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Oncolytic Virus Therapy Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Oncolytic Virus Therapy Revenue Market Share by Application (2021-2026) Table 37. Global Oncolytic Virus Therapy Revenue Market Share by Application (2027-2032) Table 38. Amgen Company Information Table 39. Amgen Business Overview Table 40. Amgen Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Amgen Oncolytic Virus Therapy Product Portfolio Table 42. Amgen Recent Development Table 43. Oncolytics Biotech Company Information Table 44. Oncolytics Biotech Business Overview Table 45. Oncolytics Biotech Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Oncolytics Biotech Oncolytic Virus Therapy Product Portfolio Table 47. Oncolytics Biotech Recent Development Table 48. Viralytics Company Information Table 49. Viralytics Business Overview Table 50. Viralytics Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Viralytics Oncolytic Virus Therapy Product Portfolio Table 52. Viralytics Recent Development Table 53. Transgene SA Company Information Table 54. Transgene SA Business Overview Table 55. Transgene SA Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Transgene SA Oncolytic Virus Therapy Product Portfolio Table 57. Transgene SA Recent Development Table 58. Oncolys BioPharma Company Information Table 59. Oncolys BioPharma Business Overview Table 60. Oncolys BioPharma Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Oncolys BioPharma Oncolytic Virus Therapy Product Portfolio Table 62. Oncolys BioPharma Recent Development Table 63. Targovax Company Information Table 64. Targovax Business Overview Table 65. Targovax Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Targovax Oncolytic Virus Therapy Product Portfolio Table 67. Targovax Recent Development Table 68. PsiOxus Therapeutics Company Information Table 69. PsiOxus Therapeutics Business Overview Table 70. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. PsiOxus Therapeutics Oncolytic Virus Therapy Product Portfolio Table 72. PsiOxus Therapeutics Recent Development Table 73. SillaJen Biotherapeutics Company Information Table 74. SillaJen Biotherapeutics Business Overview Table 75. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. SillaJen Biotherapeutics Oncolytic Virus Therapy Product Portfolio Table 77. SillaJen Biotherapeutics Recent Development Table 78. Sorrento Therapeutics Company Information Table 79. Sorrento Therapeutics Business Overview Table 80. Sorrento Therapeutics Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Sorrento Therapeutics Oncolytic Virus Therapy Product Portfolio Table 82. Sorrento Therapeutics Recent Development Table 83. Lokon Pharma Company Information Table 84. Lokon Pharma Business Overview Table 85. Lokon Pharma Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Lokon Pharma Oncolytic Virus Therapy Product Portfolio Table 87. Lokon Pharma Recent Development Table 88. Genelux Corporation Company Information Table 89. Genelux Corporation Business Overview Table 90. Genelux Corporation Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Genelux Corporation Oncolytic Virus Therapy Product Portfolio Table 92. Genelux Corporation Recent Development Table 93. Vyriad Company Information Table 94. Vyriad Business Overview Table 95. Vyriad Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. Vyriad Oncolytic Virus Therapy Product Portfolio Table 97. Vyriad Recent Development Table 98. TILT Biotherapeutics Company Information Table 99. TILT Biotherapeutics Business Overview Table 100. TILT Biotherapeutics Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 101. TILT Biotherapeutics Oncolytic Virus Therapy Product Portfolio Table 102. TILT Biotherapeutics Recent Development Table 103. Cold Genesys Company Information Table 104. Cold Genesys Business Overview Table 105. Cold Genesys Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 106. Cold Genesys Oncolytic Virus Therapy Product Portfolio Table 107. Cold Genesys Recent Development Table 108. North America Oncolytic Virus Therapy Market Size by Type (2021-2026) & (US$ Million) Table 109. North America Oncolytic Virus Therapy Market Size by Type (2027-2032) & (US$ Million) Table 110. North America Oncolytic Virus Therapy Market Size by Application (2021-2026) & (US$ Million) Table 111. North America Oncolytic Virus Therapy Market Size by Application (2027-2032) & (US$ Million) Table 112. North America Oncolytic Virus Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. North America Oncolytic Virus Therapy Market Size by Country (2021-2026) Table 114. North America Oncolytic Virus Therapy Market Size by Country (2027-2032) Table 115. Europe Oncolytic Virus Therapy Market Size by Type (2021-2026) & (US$ Million) Table 116. Europe Oncolytic Virus Therapy Market Size by Type (2027-2032) & (US$ Million) Table 117. Europe Oncolytic Virus Therapy Market Size by Application (2021-2026) & (US$ Million) Table 118. Europe Oncolytic Virus Therapy Market Size by Application (2027-2032) & (US$ Million) Table 119. Europe Oncolytic Virus Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Oncolytic Virus Therapy Market Size by Country (2021-2026) Table 121. Europe Oncolytic Virus Therapy Market Size by Country (2027-2032) Table 122. China Oncolytic Virus Therapy Market Size by Type (2021-2026) & (US$ Million) Table 123. China Oncolytic Virus Therapy Market Size by Type (2027-2032) & (US$ Million) Table 124. China Oncolytic Virus Therapy Market Size by Application (2021-2026) & (US$ Million) Table 125. China Oncolytic Virus Therapy Market Size by Application (2027-2032) & (US$ Million) Table 126. Asia Oncolytic Virus Therapy Market Size by Type (2021-2026) & (US$ Million) Table 127. Asia Oncolytic Virus Therapy Market Size by Type (2027-2032) & (US$ Million) Table 128. Asia Oncolytic Virus Therapy Market Size by Application (2021-2026) & (US$ Million) Table 129. Asia Oncolytic Virus Therapy Market Size by Application (2027-2032) & (US$ Million) Table 130. Asia Oncolytic Virus Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Asia Oncolytic Virus Therapy Market Size by Country (2021-2026) Table 132. Asia Oncolytic Virus Therapy Market Size by Country (2027-2032) Table 133. South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2021-2026) & (US$ Million) Table 134. South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2027-2032) & (US$ Million) Table 135. South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2021-2026) & (US$ Million) Table 136. South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2027-2032) & (US$ Million) Table 137. South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2021-2026) Table 139. South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2027-2032) Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Oncolytic Virus Therapy Product Image Figure 2. Global Oncolytic Virus Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Oncolytic Virus Therapy Market Share by Type: 2025 VS 2032 Figure 4. HSV-based Oncolytic Viruses Image Figure 5. Adenoviruses-based Oncolytic Viruses Image Figure 6. Vaccinia Virus-based Oncolytic Viruses Image Figure 7. Vesicular Stomatitis Virus-based Oncolytic Viruses Image Figure 8. Newcastle Disease Virus-based Oncolytic Viruses Image Figure 9. Global Oncolytic Virus Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Oncolytic Virus Therapy Market Share by Application: 2025 VS 2032 Figure 11. Melanoma Image Figure 12. Prostate Cancer Image Figure 13. Breast Cancer Image Figure 14. Ovarian Cancer Image Figure 15. Others Image Figure 16. Global Oncolytic Virus Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 18. Global Oncolytic Virus Therapy Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Oncolytic Virus Therapy Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Oncolytic Virus Therapy Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Oncolytic Virus Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Oncolytic Virus Therapy Revenue Market Share by Type (2021-2032) Figure 25. Global Oncolytic Virus Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Oncolytic Virus Therapy Revenue Market Share by Application (2021-2032) Figure 27. North America Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 28. North America Oncolytic Virus Therapy Market Share by Type (2021-2032) Figure 29. North America Oncolytic Virus Therapy Market Share by Application (2021-2032) Figure 30. North America Oncolytic Virus Therapy Market Share by Country (2021-2032) Figure 31. United States Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 32. Canada Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 34. Europe Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 35. Europe Oncolytic Virus Therapy Market Share by Type (2021-2032) Figure 36. Europe Oncolytic Virus Therapy Market Share by Application (2021-2032) Figure 37. Europe Oncolytic Virus Therapy Market Share by Country (2021-2032) Figure 38. Germany Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 39. France Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 41. Italy Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 42. Russia Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 44. China Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 45. China Oncolytic Virus Therapy Market Share by Type (2021-2032) Figure 46. China Oncolytic Virus Therapy Market Share by Application (2021-2032) Figure 47. Asia Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 48. Asia Oncolytic Virus Therapy Market Share by Type (2021-2032) Figure 49. Asia Oncolytic Virus Therapy Market Share by Application (2021-2032) Figure 50. Asia Oncolytic Virus Therapy Market Share by Country (2021-2032) Figure 51. Japan Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 55. India Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 56. Australia Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Oncolytic Virus Therapy Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Oncolytic Virus Therapy Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Oncolytic Virus Therapy Market Share by Country (2021-2032) Figure 61. Brazil Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 66. UAE Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 68. Chile Oncolytic Virus Therapy Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • HSV-based Oncolytic Viruses
  • Adenoviruses-based Oncolytic Viruses
  • Vaccinia Virus-based Oncolytic Viruses
  • Vesicular Stomatitis Virus-based Oncolytic Viruses
  • Newcastle Disease Virus-based Oncolytic Viruses
Applications
  • Melanoma
  • Prostate Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Others
Companies covered
  • Amgen
  • Oncolytics Biotech
  • Viralytics
  • Transgene SA
  • Oncolys BioPharma
  • Targovax
  • PsiOxus Therapeutics
  • SillaJen Biotherapeutics
  • Sorrento Therapeutics
  • Lokon Pharma
  • Genelux Corporation
  • Vyriad
  • TILT Biotherapeutics
  • Cold Genesys

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 HSV-based Oncolytic Viruses
  5. 1.2.3 Adenoviruses-based Oncolytic Viruses
  6. 1.2.4 Vaccinia Virus-based Oncolytic Viruses
  7. 1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
  8. 1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Melanoma
  12. 1.3.3 Prostate Cancer
  13. 1.3.4 Breast Cancer
  14. 1.3.5 Ovarian Cancer
  15. 1.3.6 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Oncolytic Virus Therapy Growth Trends by Region
  18. 1.5.1 Global Oncolytic Virus Therapy Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Oncolytic Virus Therapy Market Size by Region (2021-2026)
  20. 1.5.3 Oncolytic Virus Therapy Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Oncolytic Virus Therapy Market Dynamics
  1. 2.1 Oncolytic Virus Therapy Industry Trends
  2. 2.2 Oncolytic Virus Therapy Industry Drivers
  3. 2.3 Oncolytic Virus Therapy Industry Opportunities and Challenges
  4. 2.4 Oncolytic Virus Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Oncolytic Virus Therapy Revenue by Company (2021-2026)
  2. 3.2 Global Oncolytic Virus Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Oncolytic Virus Therapy Key Company Head office and Area Served
  4. 3.4 Global Oncolytic Virus Therapy Company, Product Type & Application
  5. 3.5 Global Oncolytic Virus Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Oncolytic Virus Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Oncolytic Virus Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Oncolytic Virus Therapy Tier 1, Tier 2, and Tier 3
4 Oncolytic Virus Therapy Market by Type
  1. 4.1 Global Oncolytic Virus Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Oncolytic Virus Therapy Market Size by Type (2021-2032)
  3. 4.3 Global Oncolytic Virus Therapy Market Size Share by Type (2021-2032)
5 Oncolytic Virus Therapy Market by Application
  1. 5.1 Global Oncolytic Virus Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Oncolytic Virus Therapy Market Size by Application (2021-2032)
  3. 5.3 Global Oncolytic Virus Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Amgen
  2. 6.1.1 Amgen Company Information
  3. 6.1.2 Amgen Business Overview
  4. 6.1.3 Amgen Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Amgen Oncolytic Virus Therapy Product Portfolio
  6. 6.1.5 Amgen Recent Developments
  7. 6.2 Oncolytics Biotech
  8. 6.2.1 Oncolytics Biotech Company Information
  9. 6.2.2 Oncolytics Biotech Business Overview
  10. 6.2.3 Oncolytics Biotech Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Oncolytics Biotech Oncolytic Virus Therapy Product Portfolio
  12. 6.2.5 Oncolytics Biotech Recent Developments
  13. 6.3 Viralytics
  14. 6.3.1 Viralytics Company Information
  15. 6.3.2 Viralytics Business Overview
  16. 6.3.3 Viralytics Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Viralytics Oncolytic Virus Therapy Product Portfolio
  18. 6.3.5 Viralytics Recent Developments
  19. 6.4 Transgene SA
  20. 6.4.1 Transgene SA Company Information
  21. 6.4.2 Transgene SA Business Overview
  22. 6.4.3 Transgene SA Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Transgene SA Oncolytic Virus Therapy Product Portfolio
  24. 6.4.5 Transgene SA Recent Developments
  25. 6.5 Oncolys BioPharma
  26. 6.5.1 Oncolys BioPharma Company Information
  27. 6.5.2 Oncolys BioPharma Business Overview
  28. 6.5.3 Oncolys BioPharma Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Oncolys BioPharma Oncolytic Virus Therapy Product Portfolio
  30. 6.5.5 Oncolys BioPharma Recent Developments
  31. 6.6 Targovax
  32. 6.6.1 Targovax Company Information
  33. 6.6.2 Targovax Business Overview
  34. 6.6.3 Targovax Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Targovax Oncolytic Virus Therapy Product Portfolio
  36. 6.6.5 Targovax Recent Developments
  37. 6.7 PsiOxus Therapeutics
  38. 6.7.1 PsiOxus Therapeutics Company Information
  39. 6.7.2 PsiOxus Therapeutics Business Overview
  40. 6.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Product Portfolio
  42. 6.7.5 PsiOxus Therapeutics Recent Developments
  43. 6.8 SillaJen Biotherapeutics
  44. 6.8.1 SillaJen Biotherapeutics Company Information
  45. 6.8.2 SillaJen Biotherapeutics Business Overview
  46. 6.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Product Portfolio
  48. 6.8.5 SillaJen Biotherapeutics Recent Developments
  49. 6.9 Sorrento Therapeutics
  50. 6.9.1 Sorrento Therapeutics Company Information
  51. 6.9.2 Sorrento Therapeutics Business Overview
  52. 6.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Product Portfolio
  54. 6.9.5 Sorrento Therapeutics Recent Developments
  55. 6.10 Lokon Pharma
  56. 6.10.1 Lokon Pharma Company Information
  57. 6.10.2 Lokon Pharma Business Overview
  58. 6.10.3 Lokon Pharma Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Lokon Pharma Oncolytic Virus Therapy Product Portfolio
  60. 6.10.5 Lokon Pharma Recent Developments
  61. 6.11 Genelux Corporation
  62. 6.11.1 Genelux Corporation Company Information
  63. 6.11.2 Genelux Corporation Business Overview
  64. 6.11.3 Genelux Corporation Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Genelux Corporation Oncolytic Virus Therapy Product Portfolio
  66. 6.11.5 Genelux Corporation Recent Developments
  67. 6.12 Vyriad
  68. 6.12.1 Vyriad Company Information
  69. 6.12.2 Vyriad Business Overview
  70. 6.12.3 Vyriad Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Vyriad Oncolytic Virus Therapy Product Portfolio
  72. 6.12.5 Vyriad Recent Developments
  73. 6.13 TILT Biotherapeutics
  74. 6.13.1 TILT Biotherapeutics Company Information
  75. 6.13.2 TILT Biotherapeutics Business Overview
  76. 6.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Product Portfolio
  78. 6.13.5 TILT Biotherapeutics Recent Developments
  79. 6.14 Cold Genesys
  80. 6.14.1 Cold Genesys Company Information
  81. 6.14.2 Cold Genesys Business Overview
  82. 6.14.3 Cold Genesys Oncolytic Virus Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Cold Genesys Oncolytic Virus Therapy Product Portfolio
  84. 6.14.5 Cold Genesys Recent Developments
7 North America
  1. 7.1 North America Oncolytic Virus Therapy Market Size (2021-2032)
  2. 7.2 North America Oncolytic Virus Therapy Market Size by Type
  3. 7.2.1 North America Oncolytic Virus Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America Oncolytic Virus Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America Oncolytic Virus Therapy Market Share by Type (2021-2032)
  6. 7.3 North America Oncolytic Virus Therapy Market Size by Application
  7. 7.3.1 North America Oncolytic Virus Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America Oncolytic Virus Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America Oncolytic Virus Therapy Market Share by Application (2021-2032)
  10. 7.4 North America Oncolytic Virus Therapy Market Size by Country
  11. 7.4.1 North America Oncolytic Virus Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Oncolytic Virus Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America Oncolytic Virus Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America Oncolytic Virus Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Oncolytic Virus Therapy Market Size (2021-2032)
  2. 8.2 Europe Oncolytic Virus Therapy Market Size by Type
  3. 8.2.1 Europe Oncolytic Virus Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Oncolytic Virus Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Oncolytic Virus Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe Oncolytic Virus Therapy Market Size by Application
  7. 8.3.1 Europe Oncolytic Virus Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Oncolytic Virus Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Oncolytic Virus Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe Oncolytic Virus Therapy Market Size by Country
  11. 8.4.1 Europe Oncolytic Virus Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Oncolytic Virus Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Oncolytic Virus Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Oncolytic Virus Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Oncolytic Virus Therapy Market Size (2021-2032)
  2. 9.2 China Oncolytic Virus Therapy Market Size by Type
  3. 9.2.1 China Oncolytic Virus Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China Oncolytic Virus Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China Oncolytic Virus Therapy Market Share by Type (2021-2032)
  6. 9.3 China Oncolytic Virus Therapy Market Size by Application
  7. 9.3.1 China Oncolytic Virus Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China Oncolytic Virus Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China Oncolytic Virus Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Oncolytic Virus Therapy Market Size (2021-2032)
  2. 10.2 Asia Oncolytic Virus Therapy Market Size by Type
  3. 10.2.1 Asia Oncolytic Virus Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Oncolytic Virus Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Oncolytic Virus Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia Oncolytic Virus Therapy Market Size by Application
  7. 10.3.1 Asia Oncolytic Virus Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Oncolytic Virus Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Oncolytic Virus Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia Oncolytic Virus Therapy Market Size by Country
  11. 10.4.1 Asia Oncolytic Virus Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Oncolytic Virus Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Oncolytic Virus Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Oncolytic Virus Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Oncolytic Virus Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Oncolytic Virus Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Oncolytic Virus Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Oncolytic Virus Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst